1. Home
  2. NX vs NEO Comparison

NX vs NEO Comparison

Compare NX & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

HOLD

Current Price

$18.58

Market Cap

852.1M

Sector

Industrials

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$10.60

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NX
NEO
Founded
1927
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Precision Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
852.1M
1.2B
IPO Year
2008
2008

Fundamental Metrics

Financial Performance
Metric
NX
NEO
Price
$18.58
$10.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$28.00
$13.38
AVG Volume (30 Days)
286.5K
1.3M
Earning Date
06-04-2026
04-28-2026
Dividend Yield
1.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,837,641,000.00
N/A
Revenue This Year
$4.26
$10.63
Revenue Next Year
$1.77
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
43.81
N/A
52 Week Low
$11.04
$4.72
52 Week High
$22.90
$13.74

Technical Indicators

Market Signals
Indicator
NX
NEO
Relative Strength Index (RSI) 49.34 74.64
Support Level $18.30 $9.35
Resistance Level $20.24 $10.66
Average True Range (ATR) 0.74 0.45
MACD 0.06 0.18
Stochastic Oscillator 61.78 95.96

Price Performance

Historical Comparison
NX
NEO

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: